Ustekinumab serum concentrations are associated with clinical outcomes in Crohn's disease - a regional multi-center pilot study.
Thomann AK, Schulte LA, Globig AM, Hoffmann P, Klag T, Itzel T, Teufel A, Schreiner R, Scheffe N, Ebert MP, Wehkamp J, Gauss A, Hasselblatt P, Klaus J, Reindl W.
Thomann AK, et al. Among authors: hoffmann p.
Z Gastroenterol. 2020 May;58(5):439-444. doi: 10.1055/a-1088-1461. Epub 2020 Feb 11.
Z Gastroenterol. 2020.
PMID: 32045954
English.